How do you measure true profitability when value is created across multiple legal entities, plants, countries, and business lines?

For many global organizations, this is no longer a theoretical management accounting question – it is a practical challenge that affects standard cost calculation, transfer pricing, margin analysis, and executive decision-making. A material may be produced in one entity, transferred across borders, further processed in another plant, and ultimately sold under a different business line or operating segment. From a legal, group, and management reporting perspective, each view may tell a different story.

In my latest blog, I explore how SAP S/4HANA extends parallel valuation with Segmentation Valuation, enabling companies to calculate and analyze costs and margins at additional organizational levels such as operating division and business unit. Using a pharma-inspired scenario, I walk through how segmentation valuation can help organizations better understand value-add across the chain, eliminate internal markups where relevant, and gain a clearer view of net chain margin across business lines.

I also touch on Financial Chains in Value Chain Analysis and how this area is expected to evolve further with the planned Financial Chain Valuation Segment capability.

Source link